Gene expression analysis of non-clear-cell renal cell carcinoma and clear-cell renal cell carcinoma kidney cancers
RNA-seq (gene expression) · human · 140 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Kidney cancerThis series is part of our curated briefing on it.
- Samples
- 140 samples: 140 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Non-Clear Cell Renal Cell Carcinoma Has an Immune-Cold Phenotype That Affects Response to Immune Checkpoint InhibitorsMolecular cancer research : MCR · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE312695_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1375726 and SRA study SRP651776. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 140 sample titles: 140 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9351555 114T
- GSM9351556 141T
- GSM9351557 143T
- GSM9351558 147T
- GSM9351559 14T
- GSM9351560 154T
- GSM9351561 166T
- GSM9351562 169T
- GSM9351563 187T
- GSM9351564 207T
- GSM9351565 218T
- GSM9351566 230T
- GSM9351567 234T
- GSM9351568 235T
- GSM9351569 250T
- GSM9351570 253T
- GSM9351571 261T
- GSM9351572 332T
- GSM9351573 344T
- GSM9351574 346T
- GSM9351575 382T
- GSM9351576 402T
- GSM9351577 409T
- GSM9351578 411T
- GSM9351579 414T
- GSM9351580 461T
- GSM9351581 463T
- GSM9351582 464T
- GSM9351583 469T
- GSM9351584 470T
- GSM9351585 479T
- GSM9351586 487T
- GSM9351587 490T
- GSM9351588 492T
- GSM9351589 496T
- GSM9351590 497T
- GSM9351591 4T
- GSM9351592 502T
- GSM9351593 503T
- GSM9351594 504T
+ 100 more — browse all 140 samples with per-sample file links →
- GSE216495 Nonclinical in-vitro evaluation of the transcriptomic and metabolic effects of immune checkpoint inhibitors on sunitinib-resistant renal cell carcinoma 36 samples same disease briefing · shares renal
- GSE216494 Impact of sunitinib resistance on clear cell renal cell carcinoma therapeutic sensitivity in vitro 12 samples same disease briefing · shares renal
- GSE174740 Drug repurposing identifies a synergistic high-order drug combination to treat sunitinib-resistant renal cell carcinoma 11 samples same disease briefing · shares renal
- GSE193006 Transcriptome RNA sequencing data of sarcomatoid renal cell carcinoma cell line SRCC and its subclones with different phenotypes. 5 samples same disease briefing · shares renal
- GSE223688 SETD2 loss sensitizes kidney cancer cells to DNA hypomethylating agents 6 samples same disease briefing · shares kidney
- GSE19982 Gene expression discriminates chromophobe renal cell carcinoma and oncocytoma 30 samples same disease briefing · shares renal
- GSE15641 Gene signatures of progression and metastasis in renal cell cancer 92 samples same disease briefing · shares renal
- GSE214635 The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis 18 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.